Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT02114294
Eligibility Criteria:
Inclusion Criteria:
* Age 16-40 years
* Insidious onset of symptoms not related to trauma
* Symptoms more than 3 months
* A minimum of VAS 3 on VAS-W
* Peri- or retropatellar pain during or after at least two of the following: Stair ascent or descent, hopping, running, prolonged sitting, squatting, kneeling.
* Pain on one of the following: Compression of the patella, palpation of the patellar facets
Exclusion Criteria:
* Clinical findings indicative of meniscal or other intraarticular injury
* Clinical findings indicative of injury to or increased laxity of cruciate or collateral ligaments
* Findings on MRI indicative of other intraarticular pathology.
* Clinical and/or x-ray findings (plain anterior-posterior, lateral and skyline view) indicative of osteoarthritis, Osgood-Schlatter or Sinding-Larsen-Johanssen syndrome
* Clinical findings indicative of knee joint effusion
* Significant pain from hip or lumbar spine on clinical evaluation, with potential for causing referred pain to the knee or hindering the patient's ability to perform the prescribed exercises.
* Recurrent patellar subluxation or dislocation.
* Previous surgery to the knee joint
* NSAID or cortisone use over an extended period of time
* Having suffered trauma to the knee joint judged during clinical evaluation to have a significant effect on the presenting clinical condition.
* Physiotherapy or other similar treatment for patellofemoral pain syndrome within the previous 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
40 Years
Study:
NCT02114294
Study Brief:
Protocol Section:
NCT02114294